Skip to main content
Erschienen in: Endocrine 3/2018

19.03.2018 | Research Letter

Brown tumors of primary hyperparathyroidism may be a source of extrarenal 1,25-dihydroxyvitamin D production

verfasst von: Melissa Sum, Dean Larner, Martin Hewison, John P. Bilezikian

Erschienen in: Endocrine | Ausgabe 3/2018

Einloggen, um Zugang zu erhalten

Excerpt

Primary hyperparathyroidism (PHPT) is classically characterized by hypercalcemia and an elevated or inappropriately normal parathyroid hormone (PTH) concentration. Associated biochemical indices include a serum phosphorus concentration in the lower range of normal [1], total alkaline phosphatase activity in the upper range of normal [2], low 25-hydroxyvitamin D (25(OH)D) levels [3], and 1,25-dihydroxyvitamin D (1,25(OH)2D) levels that are in the upper range of normal or frankly elevated [4]. PTH facilitates the 1α-hydroxylase enzymatic conversion of 25(OH)D to 1,25(OH)2D, a property that helps to account for the classic depiction of 25(OH)D and 1,25(OH)2D D levels in PHPT [5]. Other diseases associated with overproduction of 1,25(OH)2D include sarcoidosis and tuberculosis in which macrophages in the associated granulomas have acquired the 1α-hydroxylase activity. In lymphomas as well, 1,25(OH)2D-mediated hypercalcemia has been shown to be associated with abnormal synthesis of 1,25(OH)2D by macrophages in the lymphomatous tissue [6]. Today, in parts of the world where calcium is measured routinely, most patients with PHPT lack the overt renal and skeletal manifestations of PHPT which include osteitis fibrosa cystica, a skeletal feature of PHPT characterized by marked radiographic demineralization, fibrosis, brown tumors, and cysts. Histologically, the brown tumors consist of giant cells and fibroblastic stroma. The presentation of such bone lesions is now considered to be an unusual manifestation of PHPT in countries where asymptomatic PHPT has become the predominant presentation of the disease. Thus, the elevated 1,25(OH)2D level in the usual form of PHPT seen today is appropriately assumed to be of renal origin. However, in the case of PHPT associated with brown tumors, it is possible that the macrophages contained therein could contribute to excessive extrarenal production of 1,25(OH)2D levels. …
Literatur
1.
Zurück zum Zitat S.J. Silverberg, J.P. Bilezikian. Asymptomatic Primary Hyperparathyroidism. The Parathyroids, ed. by J.P. Bilezikian (Elsevier, San Diego, 2015) S.J. Silverberg, J.P. Bilezikian. Asymptomatic Primary Hyperparathyroidism. The Parathyroids, ed. by J.P. Bilezikian (Elsevier, San Diego, 2015)
2.
Zurück zum Zitat A.G. Costa, C. Marcocci, J.P. Bilezikian. Bone Turnover Markers in Primary Hyperparathyroidism. The Parathyroids, ed. by J.P. BilezikianElsevier, San Diego, 2015) A.G. Costa, C. Marcocci, J.P. Bilezikian. Bone Turnover Markers in Primary Hyperparathyroidism. The Parathyroids, ed. by J.P. BilezikianElsevier, San Diego, 2015)
3.
Zurück zum Zitat S.J. Silverberg, Vitamin D deficiency and primary hyperparathyroidism. J. Bone Miner. Res. 22(2), 100–104 (2007)CrossRef S.J. Silverberg, Vitamin D deficiency and primary hyperparathyroidism. J. Bone Miner. Res. 22(2), 100–104 (2007)CrossRef
4.
Zurück zum Zitat S.J. Silverberg, E. Shane, T.P. Jacobs, E. Siris, J.P. Bilezikian, A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery. N. Engl. J. Med. 341(17), 1249–1255 (1999)CrossRefPubMed S.J. Silverberg, E. Shane, T.P. Jacobs, E. Siris, J.P. Bilezikian, A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery. N. Engl. J. Med. 341(17), 1249–1255 (1999)CrossRefPubMed
5.
Zurück zum Zitat J. Bollerslev, L. Rolighed, L. Mosekilde, Mild primary hyperparathyroidism and metabolism of vitamin D. IBMS Bone 8(7), 342–351 (2011)CrossRef J. Bollerslev, L. Rolighed, L. Mosekilde, Mild primary hyperparathyroidism and metabolism of vitamin D. IBMS Bone 8(7), 342–351 (2011)CrossRef
6.
Zurück zum Zitat M. Hewison, V. Kantorovich, H.R. Liker, A.J. Van Herle, P. Cohan, D. Zehnder, J.S. Adams, Vitamin D-mediated hypercalcemia in lymphoma: evidence for hormone production by tumor-adjacent macrophages. J. Bone Miner. Res. 18(3), 579–582 (2003)CrossRefPubMed M. Hewison, V. Kantorovich, H.R. Liker, A.J. Van Herle, P. Cohan, D. Zehnder, J.S. Adams, Vitamin D-mediated hypercalcemia in lymphoma: evidence for hormone production by tumor-adjacent macrophages. J. Bone Miner. Res. 18(3), 579–582 (2003)CrossRefPubMed
7.
Zurück zum Zitat B. Moosgaard, P. Vestergaard, L. Heickendorff, L. Mosekilde, Plasma 1,25-dihydroxyvitamin D levels in primary hyperparathyroidism depend on sex, body mass index, plasma phosphate and renal function. Clin. Endocrinol. 66(1), 35–42 (2007)CrossRef B. Moosgaard, P. Vestergaard, L. Heickendorff, L. Mosekilde, Plasma 1,25-dihydroxyvitamin D levels in primary hyperparathyroidism depend on sex, body mass index, plasma phosphate and renal function. Clin. Endocrinol. 66(1), 35–42 (2007)CrossRef
8.
Zurück zum Zitat S.J. Silverberg, J.P. Bilezikian. Primary hyperparathyroidism. Oxford Textbook of Endocrinology and Diabetes, ed. by J.A.H. Wass, P.M. Stewart (Oxford University Press, Oxford, England, 2011) S.J. Silverberg, J.P. Bilezikian. Primary hyperparathyroidism. Oxford Textbook of Endocrinology and Diabetes, ed. by J.A.H. Wass, P.M. Stewart (Oxford University Press, Oxford, England, 2011)
9.
Zurück zum Zitat L. Aghaghazvini, H. Sharifian, B. Rasuli, Primary hyperparathyroidism misdiagnosed as giant cell bone tumor of maxillary sinus: a case report. Iran. J. Radiol. 13(1), e13260 (2016)CrossRefPubMedPubMedCentral L. Aghaghazvini, H. Sharifian, B. Rasuli, Primary hyperparathyroidism misdiagnosed as giant cell bone tumor of maxillary sinus: a case report. Iran. J. Radiol. 13(1), e13260 (2016)CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat E. Ullah, M. Ahmad, S.A. Ali, N. Redhu, Primary hyperparathyroidism having multiple Brown tumors mimicking malignancy. Indian J. Endocrinol. Metab. 16(6), 1040–1042 (2012)CrossRefPubMedPubMedCentral E. Ullah, M. Ahmad, S.A. Ali, N. Redhu, Primary hyperparathyroidism having multiple Brown tumors mimicking malignancy. Indian J. Endocrinol. Metab. 16(6), 1040–1042 (2012)CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat L. Vera, M. Dolcino, M. Mora, S. Oddo, M. Gualco, F. Minuto, M. Giusti, Primary hyperparathyroidism diagnosed after surgical ablation of a costal mass mistaken for giant-cell bone tumor: a case report. J. Med. Case Rep. 5, 596 (2011)CrossRefPubMedPubMedCentral L. Vera, M. Dolcino, M. Mora, S. Oddo, M. Gualco, F. Minuto, M. Giusti, Primary hyperparathyroidism diagnosed after surgical ablation of a costal mass mistaken for giant-cell bone tumor: a case report. J. Med. Case Rep. 5, 596 (2011)CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat J.L. Males, W.J. Howard, D.R. Mask, J.L. Townsend, J.B. Snow, H.T. McPherson, Primary hyperparathyroidism presenting as a giant cell tumor of the maxilla. Arch. Intern. Med. 132(1), 107–111 (1973)CrossRefPubMed J.L. Males, W.J. Howard, D.R. Mask, J.L. Townsend, J.B. Snow, H.T. McPherson, Primary hyperparathyroidism presenting as a giant cell tumor of the maxilla. Arch. Intern. Med. 132(1), 107–111 (1973)CrossRefPubMed
13.
Zurück zum Zitat R. Eastell, M.L. Brandi, A.G. Costa, P. D’Amour, D.M. Shoback, R.V. Thakker, Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the fourth international workship. J. Clin. Endocrinol. Metab. 99(10), 3570–3579 (2014)CrossRefPubMed R. Eastell, M.L. Brandi, A.G. Costa, P. D’Amour, D.M. Shoback, R.V. Thakker, Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the fourth international workship. J. Clin. Endocrinol. Metab. 99(10), 3570–3579 (2014)CrossRefPubMed
14.
Zurück zum Zitat B. Moosgaard, S.E. Christensen, P. Vestergaard, L. Heickendorff, P. Christiansen, L. Mosekilde, Vitamin D metabolites and skeletal consequences in primary hyperparathyroidism. Clin. Endocrinol. 68(5), 707–715 (2008)CrossRef B. Moosgaard, S.E. Christensen, P. Vestergaard, L. Heickendorff, P. Christiansen, L. Mosekilde, Vitamin D metabolites and skeletal consequences in primary hyperparathyroidism. Clin. Endocrinol. 68(5), 707–715 (2008)CrossRef
Metadaten
Titel
Brown tumors of primary hyperparathyroidism may be a source of extrarenal 1,25-dihydroxyvitamin D production
verfasst von
Melissa Sum
Dean Larner
Martin Hewison
John P. Bilezikian
Publikationsdatum
19.03.2018
Verlag
Springer US
Erschienen in
Endocrine / Ausgabe 3/2018
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-018-1579-3

Weitere Artikel der Ausgabe 3/2018

Endocrine 3/2018 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.